MicroRNA miR-371a-3p - A Novel Serum Biomarker of Testicular Germ Cell Tumors: Evidence for Specificity from Measurements in Testicular Vein Blood and in Neoplastic Hydrocele Fluid | Zendy

KlausPeter Dieckmann | Zendy; Meike Spiekermann | Zendy; Thomas Balks | Zendy; Raphael Ikogho | Zendy; Petra Anheuser | Zendy; Werner Wosniok | Zendy; Thomas Loening | Zendy; Jörn Bullerdiek | Zendy; Gazanfer Belge | Zendy

Open Access

MicroRNA miR-371a-3p - A Novel Serum Biomarker of Testicular Germ Cell Tumors: Evidence for Specificity from Measurements in Testicular Vein Blood and in Neoplastic Hydrocele Fluid

Author(s) -

KlausPeter Dieckmann,

Meike Spiekermann,

Thomas Balks,

Raphael Ikogho,

Petra Anheuser,

Werner Wosniok,

Thomas Loening,

Jörn Bullerdiek,

Gazanfer Belge

Publication year - 2016

Publication title -

urologia internationalis

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.771

H-Index - 53

eISSN - 1423-0399

pISSN - 0042-1138

DOI - 10.1159/000444303

Subject(s) - medicine , hydrocele , biomarker , vein , testicular cancer , pathology , gastroenterology , cancer , surgery , biology , biochemistry

microRNAs (miRs)-371-3 are suggested to be novel biomarkers of germ cell tumors (GCTs), but their specificity is unresolved. We aimed at clarifying the origin of miR 371a-3p by measuring this miR in peripheral vein blood, and in fluids present in the vicinity of GCTs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research